Andrew Sinclair has joined Abingworth Management as a London-based principal, with a focus on both PIPE and open-market transactions for listed life sciences companies. He previously was with HSBC Global Markets as a senior equity analyst and director.
Abingworth, the international life sciences and healthcare investment group, has appointed Andrew Sinclair as Principal, Analyst. He will focus on evaluating new and existing opportunities in quoted life sciences and healthcare companies including open market and private transactions. He is based at the company’s headquarters in London.
Dr Sinclair has more than 8 years experience as an analyst in the pharmaceutical and biotechnology sectors. He joined Abingworth from HSBC Global Markets where he was Senior Equity Analyst, Director, responsible for investment research in the mid-cap pharmaceutical sector. Previously, Dr Sinclair held biotechnology analyst positions at Credit Suisse and SG Cowen.
Dr Sinclair completed a PhD in Chemistry and Genetic Engineering at the BBSRC Institute of Plant Science, Norwich, and holds a BSc in Microbiology from King’s College London. He qualified as a chartered accountant with KPMG.
“We are delighted to welcome Andrew to the team,” said Dr Joe Anderson, Partner. “His experience will further strengthen Abingworth’s investments in public equities. This is a great time to be investing in small public life science companies as the credit crisis and recessionary pressures have depressed share prices to a level where market valuations can bear little resemblance to intrinsic value. Andrew’s skills will be very valuable as we seek out the strongest businesses in this sector.”
Notes for Editors:
Abingworth is an international investment group dedicated exclusively to the life sciences and healthcare sector. The company invests at all stages of development including early and late-stage venture financing, growth equity and public companies.
Founded in 1973, Abingworth has a lengthy track record of building market leading companies. Abingworth has a specialist team of over 20 professionals with a broad range of skill sets and access to an extensive network of industry contacts. Abingworth has funds under management of over $1.25 billion and offices in London, Menlo Park (California) and Boston.